Anne Schlitterlau Knudsen

Anne Schlitterlau Knudsen has a diverse work experience spanning various roles and industries. Their most recent position is as a Scientist at Symphogen, a company they joined in September 2021. Prior to this, Anne worked as a Postdoctoral Researcher and a PhD fellow at Københavns Universitet - University of Copenhagen from June 2018 to August 2021. Their work there focused on vaccine development against malaria, and they also spent time as a visiting researcher at The Jenner Institute, University of Oxford.

Before their research career, Anne worked as a Research Associate at F-star Biotechnology Ltd from July 2016 to May 2018. In this role, they were involved in the discovery, engineering, and characterization of novel bispecific antibodies within the company's immuno-oncology programs.

Anne also has experience in teaching, having worked as an Upper Secondary School Teacher at EUC Syd from January 2016 to July 2016. Anne previously served as an Industrial Placement Student at MedImmune from January 2015 to July 2015, gaining industry experience during their studies.

Additionally, Anne has contributed to educational projects as a Mentor at Mercuri Urval. From November 2013 to December 2014, they mentored two bilingual teenage girls as part of a project called 'Youth education for everyone', which aimed to support the national objective of increasing the percentage of youth who complete an education program.

Overall, Anne Schlitterlau Knudsen's work experience demonstrates their expertise in scientific research, vaccine development, antibody engineering, teaching, and mentoring.

Anne Schlitterlau Knudsen earned their Bachelor of Science (B.Sc.) degree in Biotechnology from Aarhus University, which they completed between the years 2010 and 2013. Anne then pursued further education at Aarhus University, obtaining a Master of Science in Engineering (M.Sc.Eng.) degree in Biotechnology and Chemical Engineering from 2013 to 2015. In 2018, Anne enrolled in the University of Copenhagen, where they completed their Doctor of Philosophy (PhD) degree in Vaccinology in 2021. Additionally, they obtained certification in FELASA A/B/D functions from the University of Copenhagen in November 2018.